Which peptide heals injuries fastest?

For tendon, ligament, and gut: BPC-157 has the broadest preclinical literature for fastest connective-tissue healing. For muscle and broader soft-tissue: TB-500 with its longer half-life and systemic angiogenic effect. Most users who can run both stack them. There are no head-to-head human trials, so "fastest" depends on the specific tissue type.

Is BPC-157 + TB-500 the best recovery stack?

It is the most-stacked combination in research and biohacker protocols. The two cover different mechanisms (BPC-157 for connective-tissue specificity, TB-500 for muscle plus systemic angiogenesis), so they complement rather than duplicate. KLOW Combo is the single-vial alternative that bundles both plus GHK-Cu and KPV. See the BPC-157 vs TB-500 comparison page for the side-by-side breakdown.

Can I use these peptides after surgery?

Recovery peptides are commonly used in post-surgical contexts in research and biohacker communities, but every surgical recovery is individual. Pro-angiogenic compounds (BPC, TB-500, KLOW) and GHK-Cu (collagen synthesis) are the most relevant for post-surgical tissue repair. CJC/Ipa supports systemic recovery via sleep and lean-mass retention. None of these are FDA-approved for surgical recovery. Discuss with your surgeon, especially in the first 1 to 2 weeks where you want controlled inflammation as part of normal healing.

Does Peptara sell BPC-157, TB-500, KLOW, CJC/Ipa, and GHK-Cu?

Yes. All five are stocked Peptara research vials. BPC-157 has a dedicated product page. The other four route via WhatsApp for ordering and protocol setup; this is operational, not a stocking issue. Pricing is shown in the cost breakdown table above.

What is KLOW Combo and how does it compare to running BPC + TB-500 separately?

KLOW is a four-peptide blend (BPC-157 + TB-500 + GHK-Cu + KPV) in one 80mg vial. KPV is an anti-inflammatory tripeptide derived from alpha-MSH. KLOW is convenient (one vial, one daily injection) and broader-spectrum, but per-component doses are lower than running each compound separately at full dose. Pick KLOW for systemic recovery convenience; pick BPC + TB-500 separately when you want compound-specific dosing control for a targeted injury.

What is the difference between recovery peptides and growth hormone (HGH)?

HGH is full-molecule exogenous growth hormone. CJC-1295/Ipamorelin uses the GH axis but works by pulsing endogenous GH release from your own pituitary, which preserves natural feedback regulation. BPC-157 and TB-500 do not act through GH at all; they are tissue-repair peptides with separate mechanisms. Recovery peptides are generally safer than exogenous HGH because they do not override the body GH/IGF-1 feedback loop.

How long do I need to run a recovery protocol?

Most users run 4 to 8 week cycles. Acute injuries: stop when the injury is functionally healed. Chronic recovery (multi-site or slow healers): repeat 4 to 8 week cycles with 4 to 8 week breaks. KLOW and CJC/Ipa are often cycled longer (8 to 12 weeks on, 4 weeks off) for ongoing recovery support. Avoid continuous use beyond 12 to 16 weeks without a break, especially for the pro-angiogenic compounds.

Are there non-peptide alternatives for recovery?

Yes. Platelet-rich plasma (PRP) injections and stem-cell therapy are commonly compared to recovery peptides for tendon and joint injuries. Both are FDA-cleared for specific indications and use cellular biology rather than synthetic peptides. Mechanical recovery (sleep, mobility work, eccentric loading for tendons, nutrition) remains primary. Recovery peptides are best understood as adjuncts to the basics, not replacements.

Topic hub: recovery

Best Peptides for Recovery: Ranked by Use Case

Five compounds ranked by primary clinical use case. From tendon and ligament repair (BPC-157) to systemic 4-peptide blends (KLOW). All research compounds, not FDA-approved. Includes goal-based decision tree, dosing in units, and monthly cost.

Verdict in 5 lines

Tendon, ligament, gut: BPC-157 (Body Protection Compound). Deepest preclinical literature, fastest connective-tissue healing in animal models.
Muscle, soft tissue: TB-500 (thymosin beta-4 fragment). Pro-angiogenic, systemic repair, longer half-life than BPC.
Full-stack recovery: KLOW Combo. Peptara four-peptide formulation (BPC + TB-500 + GHK + KPV) for users with multiple injury sites or slow systemic healing.
Sleep-driven recovery: CJC-1295/Ipamorelin. GH-axis pulse for deeper sleep, faster overnight repair, lean-mass retention during recovery phases.
Wound healing, scar tissue, skin: GHK-Cu. Copper peptide with strongest dermatology and wound-care research base, also used for post-surgical recovery.

Ranked by primary use case

Ordering reflects primary clinical application, not trial effect size. No head-to-head human trials exist across these compounds.

Order	Peptide	Primary Use Case	Mechanism	Research Depth	Peptara Cost
1	BPC-157	Tendon, ligament, gut healing	Pro-angiogenic, growth-factor upregulation	Extensive preclinical (Sikiric et al, multiple journals 1990s to 2020s) plus small human reports	$89 to $177 first-time
2	TB-500	Muscle and soft-tissue repair	Actin-sequestering thymosin beta-4 fragment	Preclinical plus horse-racing clinical use plus human anecdote	$162 to $324 first-time
3	KLOW Combo	Full-stack systemic recovery	4-peptide blend (BPC + TB-500 + GHK-Cu + KPV)	Peptara stack formulation; literature on each individual peptide	$68 to $136 first-time
4	CJC-1295/Ipamorelin	GH-axis recovery, sleep depth, lean mass	GHRH analog plus GHRP-2 mimetic synergy	Established endocrinology literature; widely used research compound	$84 to $169 first-time
5	GHK-Cu	Wound, scar, skin/collagen recovery	Copper-binding tripeptide, dermal fibroblast activation	Strongest dermatology literature (Pickart et al), wound-healing trials	$52 to $103 first-time

Read this before quoting the ranking

Ordering is by primary clinical use case, not trial effect size. No head-to-head human trials compare these compounds. Research depth varies: BPC-157 has the broadest preclinical literature; KLOW Combo is a Peptara-formulated blend; GHK-Cu has the strongest dermatology evidence base. All five are research compounds. None are FDA-approved for general human therapeutic use. Doses and effect timelines below are derived from research protocols and biohacker community practice, not clinical trials.

Decide by injury or recovery goal

Six goal profiles, six recommendations. Pick the card that matches your tissue involvement.

Goal A

Tendon, ligament, or gut injury

Body Protection Compound. Pro-angiogenic peptide originally isolated from gastric juice. Deepest preclinical literature for connective-tissue healing (Sikiric et al, 30+ years). Common protocol: 250 to 500mcg subcutaneous near injury site, 1 to 2x daily, 4 to 8 week cycles.

Pick: BPC-157

BPC-157 product →BPC vs TB-500 →

Goal B

Muscle damage or deeper soft-tissue injury

Synthetic fragment of thymosin beta-4. Pro-angiogenic and actin-sequestering. Systemic effect, longer half-life than BPC, well-known in equine research and racing. Common protocol: 2mg (=20u) twice weekly during loading phase x 4 weeks, then 2mg weekly maintenance.

Pick: TB-500

No dedicated product page. WhatsApp for ordering.

BPC vs TB-500 comparison →

Goal C

Slow healer, multi-site, systemic recovery

Four-peptide blend: BPC-157 + TB-500 + GHK-Cu + KPV (an anti-inflammatory tripeptide). Peptara formulation. Single-vial convenience over running 3 to 4 separate vials. Common protocol: 1 to 2mg of the blend subcutaneous daily, 4 to 8 week cycles.

Pick: KLOW Combo

No dedicated product page. WhatsApp for ordering, includes protocol guide.

Goal D

Recovery via deeper sleep + lean-mass retention

GHRH analog (CJC-1295) plus GHRP mimetic (Ipamorelin) blend that pulses endogenous growth hormone. Targets sleep architecture and lean-mass preservation during recovery or training phases. Common protocol: 300mcg to 600mcg subcutaneous at bedtime, 5 days on / 2 days off to reduce receptor desensitization.

Pick: CJC-1295/Ipamorelin

No dedicated product page. WhatsApp for ordering.

Goal E

Wound, surgical incision, scar tissue, skin

Copper-binding tripeptide. Strongest peer-reviewed evidence base for wound healing and dermal renewal. Used for post-surgical recovery, scar refinement, and collagen-mediated tissue repair. Common protocol: 1 to 2mg subcutaneous daily, or topical formulations for cosmetic application.

Pick: GHK-Cu

No dedicated product page. WhatsApp for ordering.

Goal F

Tendon AND muscle: the elite stack

Most-stacked recovery pair. BPC for connective-tissue specificity, TB-500 for muscle and systemic angiogenesis. Run together at full single-compound doses; profiles complement rather than overlap.

Pick: BPC-157 + TB-500 duo

When to stack vs swap →

Mechanism groups

Three biological pathways, five compounds.

Tissue-repair (BPC + TB + KLOW)

BPC-157 upregulates growth factors (VEGF, EGF) and accelerates capillary formation at injury sites. TB-500 (thymosin beta-4 fragment) sequesters actin to enable cell migration and systemic angiogenesis. KLOW bundles BPC + TB-500 + GHK-Cu + KPV into one vial; the four cover overlapping pathways.

GH-axis recovery (CJC-1295/Ipamorelin)

CJC-1295 is a GHRH analog that extends endogenous GH pulses; Ipamorelin is a GHRP mimetic that triggers them. Stacked, the combo amplifies natural GH/IGF-1signaling during sleep, supporting overnight tissue repair and lean-mass retention without supraphysiological GH spikes.

Dermal / wound healing (GHK-Cu)

Copper-binding tripeptide with extensive Pickart-lab research. Activates dermal fibroblasts, upregulates collagen and glycosaminoglycan synthesis, and modulates the wound-healing cascade. The strongest peer-reviewed evidence base among the five hub SKUs for a specific clinical endpoint.

Cost breakdown

Peptara monthly cost ranges with first-time discount applied. Cost formula: vial price times 4.33 weeks per month, divided by weeks per vial. Weeks per vial equals vial mg divided by weekly dose mg.

Peptide	Vial	First-time / Retail	Common Dose	Monthly first-time	Monthly retail
BPC-157	20mg	$117 / $138	250 to 500mcg, 1 to 2x daily	$89 to $177	$105 to $209
TB-500	10mg	$187 / $220	2mg 2x/wk loading x 4wk, then 2mg/wk maintenance	$162 to $324	$190 to $381
KLOW Combo	80mg	$179 / $210	1 to 2mg blend SC daily	$68 to $136	$80 to $160
CJC-1295/Ipa	10mg	$130 / $153	300 to 600mcg SC at bedtime, 5d/wk	$84 to $169	$99 to $199
GHK-Cu	100mg	$170 / $200	1 to 2mg SC daily	$52 to $103	$61 to $121

Monthly cost calculation: vial price times 4.33 weeks/month divided by weeks per vial. Doses always in units, never mL. See the reconstitution guide for full math.

Stacking framework

Recovery is inherently a stacking game. What to combine, what to avoid, how to sequence.

Workhorse stacks

BPC-157 + TB-500 (the classic duo, see the comparison)
KLOW Combo + CJC-1295/Ipamorelin (systemic repair + sleep-driven recovery)
BPC-157 + GHK-Cu (gut/connective tissue + skin/wound surface healing)

Specialty stacks

TB-500 + GHK-Cu (muscle/soft tissue + wound recovery for post-surgical)
KLOW Combo solo (single-vial blend for users avoiding multi-vial protocols)
CJC/Ipa + GHK-Cu (sleep-driven recovery + skin/collagen aesthetic refinement)

Sequencing

Acute injuries: start BPC-157 within 48 to 72 hours, add TB-500 from week 1 if soft-tissue involvement is significant
Chronic recovery: KLOW as base, layer CJC/Ipa during higher-training phases
Cycle length: 4 to 8 weeks on, 4 to 8 weeks off, then reassess
Stack only different mechanisms; do NOT stack two compounds covering the same pathway (e.g., BPC + KLOW is redundant since KLOW contains BPC)

Regulatory and research-compound status

All five peptides on this page are research compounds. None are FDA-approved for general human therapeutic use. BPC-157 has the deepest body of preclinical literature (Sikiric et al, 30+ years, multiple peer-reviewed journals). TB-500 is the synthetic fragment of thymosin beta-4 (a 43-amino-acid protein); thymosin beta-4 itself has been studied in human cardiac and corneal trials. GHK-Cu is the only compound with substantial human dermatology trial data (Pickart et al). KLOW Combo is a Peptara-formulated blend: the individual components are studied; the specific blend is not the subject of dedicated trial literature. CJC-1295/Ipamorelin combinations are common in endocrinology research and biohacker community use but not FDA-approved as a finished pharmaceutical.

Side effects by mechanism group

Three profiles to know. Notes below are not exhaustive.

Tissue-repair (BPC + TB + KLOW)

Generally well-tolerated in research and biohacker reports. Injection-site reactions (redness, mild swelling) most common. Theoretical concerns: pro-angiogenic mechanism could be problematic in users with active malignancy (cancer cells require angiogenesis). Avoid in active or recent cancer diagnoses without physician oversight. KLOW includes KPV which is generally anti-inflammatory; same theoretical malignancy caveat applies.

GH-axis (CJC-1295/Ipamorelin)

Possible water retention, mild numbness or tingling in extremities (most common first 2 to 3 weeks), occasional vivid dreams. Elevations in IGF-1 with longer protocols, monitor lab values if running over 3 months. Avoid in active malignancy and active diabetic retinopathy. Hypoglycemia risk if stacked with insulin or sulfonylureas.

Copper peptide (GHK-Cu)

Localized injection-site reactions; some users report blue-tinted skin discoloration at injection sites (copper-related, reversible). Topical formulations: rare skin irritation. Copper accumulation theoretically possible with long, high-dose systemic protocols (not clinically reported but a known mechanism caveat). Avoid in Wilson disease (copper-handling disorder).

Timeline expectations

How long until you see effects.

Peptide	Dose Schedule	Time to Visible Effect
BPC-157	Daily SC (1 to 2x)	1 to 3 weeks for early pain/range improvement; 4 to 8 weeks for measurable tendon/gut endpoints
TB-500	Loading 2x/wk x 4wk, then weekly	2 to 4 weeks for early effect; full systemic effect at 6 to 12 weeks
KLOW Combo	Daily SC	2 to 6 weeks; longer than single compounds because per-peptide doses are lower than running each individually
CJC-1295/Ipa	Nightly SC, 5d/wk	1 to 2 weeks for sleep depth; 4 to 8 weeks for body composition and recovery feel
GHK-Cu	Daily SC and/or topical	2 to 6 weeks for wound/scar endpoints; 8 to 12 weeks for collagen/skin texture changes

Frequently asked questions

Next steps

BPC-157 product page

Body Protection Compound. 20mg/vial. $117 first-time / $138 retail. The recovery anchor: start here for tendon and gut.

View product

BPC-157 vs TB-500

When to swap and when to stack. The cluster anchor for the recovery sub-cluster.

Open comparison

How to reconstitute your vial

4-step method plus units-not-mL calculator. Required reading before any research-vial protocol.

Open guide

Full /vs/* cluster

BPC vs TB-500 Reta vs Tirz Reta vs Ozempic Tirz vs Ozempic

Different goal? Switch hubs

If your primary goal is body composition (fat loss) rather than recovery, the fat-loss hub is the right entry point.

Peptides for Fat Loss (ranked guide) →

FAQ →About Peptara →Find your protocol quiz →

Not sure which recovery peptide fits

Not sure which recovery peptide fits your injury or protocol? Message the Peptara team on WhatsApp.

For TB-500, KLOW Combo, CJC-1295/Ipamorelin, and GHK-Cu (no dedicated product page yet), WhatsApp is the order channel and includes protocol setup.

Chat on WhatsApp Browse all 15 peptides →